Health
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%
Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to…
Topic
1 story
Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to…